Meredith Pelster, MD, MSCI
Assistant Director, Gastrointestinal Research, Sarah Cannon Research Institute
Dr. Pelster joined Sarah Cannon Research Institute (SCRI) in 2021 and serves as assistant director of gastrointestinal (GI) research for SCRI, specializing in GI cancer as well as head and neck cancer research.
Dr. Pelster received her Doctorate of Medicine from Vanderbilt University. She completed her fellowship in hematology and medical oncology at the MD Anderson Cancer Center and her residency and Masters of Science in clinical investigation at Northwestern University. She practices with Tennessee Oncology, PLLC, at the SCRI drug development unit in Nashville, Tenn.